TDC
CEMI

Thompson Davis & Co’s Chembio diagnostics, Inc. CEMI Stock Holding History

Thompson Davis & Co’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,500
Closed -$9K – 1240
2017
Q3 		$9K Buy
+1,500
New +$9.23K 0.02% 729
2016
Q3 		– Sell
-25,963
Closed -$213K – 1246
2016
Q2 		$213K Buy
25,963
+9,700
+60% +$75.6K 0.34% 78
2016
Q1 		$97K Buy
+16,263
New +$84K 0.14% 158
2015
Q3 		– Sell
-6,608
Closed -$32K – 1369
2015
Q2 		$32K Sell
6,608
-4,089
-38% -$18.9K 0.04% 414
2015
Q1 		$43K Sell
10,697
-52,903
-83% -$208K 0.05% 322
2014
Q4 		$249K Buy
+63,600
New +$263K 0.29% 71

Other funds holding CEMI

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Thompson Davis & Co's CEMI Position: Q4 2017 in Review

Thompson Davis & Co sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2017, closing a stake of 1,500 shares — an estimated $9K sold.

Thompson Davis & Co first reported a position in CEMI in Q4 2014 and held it in 6 quarters. The position peaked at $249K in Q4 2014. 23 funds tracked by Wall St. Rank hold CEMI as of Q4 2017.

  • Thompson Davis & Co reported no remaining Chembio diagnostics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 1,500 Chembio diagnostics, Inc. shares in Q4 2017, an estimated $9K.
  • Thompson Davis & Co first reported a position in Chembio diagnostics, Inc. in Q4 2014 and held it in 6 quarters.
  • Thompson Davis & Co's Chembio diagnostics, Inc. position peaked at $249K in Q4 2014.
  • 23 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.